Advertisements



We are Sorry, This Page doesn't Exist


J.M. Smucker rallies 2% to $111.49 amid CAGNY presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Omeros says EMA appointed rapporteurs for MAA for OMS721

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2019

Omeros Corporation: OMS721 In HSCT-TMA And IgAN Plus Omidria Worth $2.5 Billion

Omeros Corporation: OMS721 In HSCT-TMA And IgAN Plus Omidria Worth $2.5 Billion.....»»

Category: topSource: seekingalphaJun 5th, 2018

Omeros says OMS721 receives European Orphan Drug designation positive opinion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Omeros: OMS721 designated Orphan Medicinal Product in EU for HSCT

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Omeros Shares Fall Over 40% On Renal Disease Trial Results

Biopharma Omeros Corporation (NASDAQ: OMER) released additional data Monday from the company’s OMS721 clinical trial in renal disease.  read more.....»»

Category: blogSource: benzingaOct 1st, 2018

Omeros granted FDA Orphan Drug Designation for OMS721

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 23rd, 2018

Omeros submits pediatric investigational plan for use of OMS721 to EMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 6th, 2018

Omeros establishes independent committee for OMS721 Phase 3 program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 20th, 2018

Omeros finalizes clinical plan for OMS721 submission with FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 17th, 2019

Omeros Finalizes Clinical Plan For Kidney Disease Treatment, Reports Additional Positive Phase 2 Data

Omeros Corporation (NASDAQ: OMER) shares are seeing buying interest Thursday following a clinical update on its lead human monoclonal antibody OMS721, which is being evaluated for IgA nephropathy. read more.....»»

Category: blogSource: benzingaJan 17th, 2019

Omeros streamlines required work for OMS721 BLA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2019

"Dogecoin Killer" Shiba Inu Burn Rate Spikes 800%, Crypto Market Rallies As Sentiment Soars And More: This Week In Cryptocurrency

The week was a rollercoaster ride for the cryptocurrency market. The crypto world was buzzing with news, from Shiba Inu’s surging burn rate to speculation of certain altcoins becoming irrelevant. read more.....»»

Category: blogSource: benzingaMay 5th, 2024

This Ticker Turns Nvidia Into a 9.2% Dividend Payer

Stock market rallies climb walls of worry......»»

Category: topSource: redinewsMay 4th, 2024

Camposol Holding PLC"s Invitation to the First Quarter 2024 Financial Results Presentation

Camposol Holding PLC"s Invitation to the First Quarter 2024 Financial Results Presentation.....»»

Category: earningsSource: benzingaMay 3rd, 2024

Full Year 2023 Shield Therapeutics PLC Earnings Presentation Transcript

Related Stocks: OTCPK:SHIEF,.....»»

Category: blogSource: gurufocusMay 2nd, 2024

Q1 2024 Goldwind Science & Technology Co Ltd Earnings Presentation Transcript

Related Stocks: OTCPK:XJNGF,.....»»

Category: blogSource: gurufocusMay 2nd, 2024

Trump slurs words and struggles to gain crowd enthusiasm in Midwest rallies

Trump slurs words and struggles to gain crowd enthusiasm in Midwest rallies.....»»

Category: topSource: yahooMay 1st, 2024

4 Online Resources Buyer Agents Can Use to Impress Clients

In a post-National Association of REALTORS® (NAR) settlement world, buyer agents know they will need more than a quick stat or a flashy presentation t.....»»

Category: realestateSource: rismediaMay 1st, 2024

Amazon earnings results: AMZN stock rallies after hours from AI-fueled AWS growth, Q1 sales and profit beats

Amazon reported quarterly earnings today, beating sales and revenue projections. AMZN shares rose 3% after hours from AWS' AI-fueled growth. Spencer Platt/Getty ImagesAmazon reported first-quarter ea.....»»

Category: personnelSource: nytApr 30th, 2024